We are live on ! Find out more
RC

Rangeley Capital Portfolio holdings

AUM $103M
1-Year Est. Return 77.32%
This Fund
S&P 500
This Quarter Est. Return
+28.51%
1 Year Est. Return
+77.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$116M
AUM Growth
+$31.8M
Cap. Flow
+$19.7M
Cap. Flow %
17.01%
Top 10 Hldgs %
43.17%
Holding
151
New
78
Increased
26
Reduced
12
Closed
24

Sector Composition

Rank Sector Weight
1 Healthcare 32.16%
2 Financials 11.15%
3 Energy 9.32%
4 Communication Services 8.43%
5 Materials 7.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KDK
151
Kodiak AI
KDK
$775M
-11,920
Closed -$135K

Similar funds

Rangeley Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Rangeley Capital held 151 positions worth $116M, up 38% from $83.8M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Rangeley Capital deployed $19.7M of net new capital in Q3 2025, opening 78 new positions and adding to 26 existing holdings. Its largest new stake was Yext: 545,000 shares worth $4.64M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 47% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was Delek US, an estimated $2.79M trimmed.

  • Rangeley Capital's largest Q3 2025 buy was Yext: 545,000 shares worth $4.64M.
  • Rangeley Capital added most to GSR III Acquisition Corp in Q3 2025, an estimated $941K increase.
  • Rangeley Capital's biggest Q3 2025 reduction was Delek US, cutting an estimated $2.79M.
  • Rangeley Capital fully exited Sage Therapeutics in Q3 2025, selling an estimated $6.66M.
  • Rangeley Capital's ten largest holdings make up 43% of its $116M portfolio in Q3 2025.
  • Rangeley Capital opened 78 new positions and closed 24 in Q3 2025.
  • Rangeley Capital's portfolio value rose 38% quarter-over-quarter to $116M.

Based on Rangeley Capital's 13F filing for Q3 2025, filed 14 Nov 2025.